Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Suzuki, Yosuke [VerfasserIn]   i
 Witt, Lukas [VerfasserIn]   i
 Mier, Walter [VerfasserIn]   i
 Mikus, Gerd [VerfasserIn]   i
 Markert, Christoph [VerfasserIn]   i
 Haefeli, Walter E. [VerfasserIn]   i
 Burhenne, Jürgen [VerfasserIn]   i
Titel:Ultra-sensitive and selective quantification of endothelin-1 in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry
Verf.angabe:Yosuke Suzuki, Lukas Witt, Walter Mier, Gerd Mikus, Christoph Markert, Walter E. Haefeli, Jürgen Burhenne
Umfang:7 S.
Fussnoten:Available online 29 April 2017 ; Gesehen am 20.06.2018
Titel Quelle:Enthalten in: Journal of pharmaceutical and biomedical analysis
Jahr Quelle:2017
Band/Heft Quelle:142(2017), S. 84-90
ISSN Quelle:1873-264X
Abstract:Endothelin-1 (ET-1) is a potent endogenous vasoconstrictor peptide and the plasma concentrations are commonly quantified by immunoassays such as enzyme-linked immuno-sorbent assays (ELISA) with the disadvantage of possible cross-reactivity with closely related endothelin derivatives. The aim of this study was to develop and validate an ultra-sensitive and selective assay for the quantification of ET-1 in human plasma, using ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) after solid phase extraction. The assay fulfilled the requirements of the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) guidelines for assay validation, with a lower limit of quantification of 1.5pg/mL for ET-1. Recovery rates from plasma ranged between 80.8% and 93.6%, and matrix effect varied between 121% and 135%. The assay was successfully applied to assess the time course of plasma ET-1 concentrations in two human volunteers after co-administration of bosentan and clarithromycin. In this trial, the concentrations measured by UPLC-MS/MS were slightly lower than those measured by ELISA, with a strong positive correlation between the two methods. Our novel UPLC-MS/MS method is applicable to the clinical setting and may have better selectivity for ET-1 than ELISA.
DOI:doi:10.1016/j.jpba.2017.04.038
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Verlag: http://dx.doi.org/10.1016/j.jpba.2017.04.038
 Verlag: http://www.sciencedirect.com/science/article/pii/S0731708517305319
 DOI: https://doi.org/10.1016/j.jpba.2017.04.038
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1576580636
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68263299   QR-Code
zum Seitenanfang